awards grant
- Developing a novel cell therapy to treat Type 1 diabetes
- Development of viral Fc receptor targeting vaccines for prevention of congenital CMV
- First-in-Class Dual AR-V7/AR-fl Molecular Glue Degrader for Prostate Cancer Treatment
- Immunologic Eradication of Myeloproliferative Neoplasm Stem Cells
- Magnet Actuated Cranial (M.A.C) Bioresorbable Distraction System
- Subcutaneous transplantation of Islet-specific endothelial cell vascularized islets to treat diabetes
- T cells selected from lymph node acquisition for adoptive cell treatment of solid tumors